InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,821.90
(
-0.11%
)
Post# of 252431
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: DewDiligence post# 78750

Sunday, 05/31/2009 6:26:35 PM

Sunday, May 31, 2009 6:26:35 PM

Post# of 252431
The response rate shrank markedly from the ASCO abstract released in mid May to the actual ASCO presentation. In the abstract, the RR was 10/26 = 38.5% (#msg-37841570); in the actual presentation, the RR was 7/46 = 15.2% (http://finance.yahoo.com/news/Exelixis-and-BMS-Report-Phase-bw-15392385.html ).

Did Dr. Scangos offer any explanation for this discrepancy on the webcast?

Isn't it obvious


The independent review "is a very conservative picture," said Renzo Canetta, head of global oncology development at Bristol-Myers

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up